Related Experiment Video
Updated: Aug 18, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
[Resistant hypertension]
1Département de Cardiologie de l'Hôpital de la Tour, Rue de l'Université I, Genève. s.ciaroni.card@bluewin.ch
Abstract:
Hypertension is a cardiovascular risk factor which needs a good evaluation before treatment. When this latter is decided, the target is to normalize high blood pressure. This requires a complete information of the patient; the latter will also receive individualized non pharmacological advices and also possibly different antihypertensive drugs. When blood pressure does not normalize, one must check the pressure measurement technique, the compliance to treatment and potential pharmacological interferences. Secondary hypertension is only considered if resistance to therapy cannot be found. It should be remembered that obesity and sleep apnea disorders are responsible of many instances of resistant hypertension.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension I: Introduction
Hypertension IV: Drug Therapy and Lifestyle Modifications
Heart Failure V: Medical Management
Hypertension III: Clinical Manifestations and Diagnostic Studies
Antihypertensive Drugs: Angiotensin II Receptor Blockers
